Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - RETAINED EARNINGS
Retained Earnings HALO - Halozyme Therapeutics, Inc.
360 M
LAST VALUE
58.52%
2 YEAR CAGR
21.02%
5 YEAR CAGR
10.84%
10 YEAR CAGR